<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <title></title>
        <meta name="description" content="">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        
        <link rel="stylesheet" href="practices5.css">
    </head>
    <body>
        <table>
            <colgroup>
            <col span="1" style="background-color: aquamarine;">
            <col span="1" >
            <col span="1" style="background-color: pink;"></row>
            <col span="1" style="background-color: lightgoldenrodyellow;">
        </colgroup>
        <h2>HTML Practice 5</h2>
        <B>Table 1 : Stem Cell Companies Active in Ophthalmology</B>
        <tr>
            <th>Company</th>
            <th>Collaborator(s)</th>
            <th>Cell Type</th>
            <th>Applications</th>
        </tr>
        <tr>
            <td>Advanced Cell
                Technology Inc.
                (ACT)
                </td>
            <td>Oregon Health & Science
                University (OHSU)
            <li>Moorfields Eye Hosp.</li>

            <li>UCLA/Jules Stein</li>
            <li>Wills Eye Hospital</li>
            <li>Aberdeen Royal Infirm.</li>
            <li>Bascom Palmer</li>
            <li>Mass Eye & Ear</li>
             </td>
             <td>hESCs </td>
             <td>RPE cells for retinal
                diseases, including Dry
                AMD NCT01344993
                and Stargardt’s
                NCT01345006
                NCT01469832
                </td>
        </tr>
        <tr>
            <td>AstraZeneca</td>
            <td>Univ. College London (UCL)</td>
            <td>hESCs</td>
            <td>Diabetic Retinopathy</td>
        </tr>
        <tr>
            <td>BetaStem
                Therapeutics
                </td>
            <td>University of Florida</td>
            <td>CD34+ cells
                from human
                cord blood or
                bone marrow
                </td>
            <td>Diabetic Retinopathy
                (in preparation for
                human clinical trials)
                </td>

        </tr>
        <tr>
            <td>Cell Cure
                Neurosciences</td>
            <td>TEVA </td>
            <td>hESCs </td>
            <td>RPE cells for dry AMD
            </td>

        </tr>
        <tr>
            <td>CellSeed France
                SARL</td>
            <td>FGK Clinical Reserach GmbH
            </td>
            <td>oral mucosa
                epithelial cells</td>
            <td>CAOMECS* for Corneal
                tissue repair in those with
                limbal cell deficiencies
                NCT01489501</td>

        </tr>
        <tr>
            <td>Centre Hospitalier
                d’Ophth. des
                Quinze-Vingts,
                Paris
                </td>
            <td>Etablissement Francais du Sang liede-France
                </td>
                <td>transplantation
                    of cultured
                    allogenic or
                    autologous
                    limbal stem cells</td>
                    <td>limbal stem cell
                        deficiency
                        NCT01619189
                        </td>
        </tr>
        <tr>
            <td>CHA Bio &
                Diostech
                (S. Korea)</td>
                <td>Licensee of ACT </td>
                <td>hESCs</td>
                <td>RPE cells for retinal
                    diseases, including
                    Stargardt’s
                    NCT01625559
                    and
                    Dry AMD
                    NCT01674829
                    </td>
        </tr>
        <tr>
            <td>Mahidol Univ.
                (Thailand)
                </td>
                <td>Ministry of Health, Thailand </td>
                <td>bone marrowderived
                    Mesenchymal
                    stem cells
                    corneal epithelial
                    stem cell</td>
                    <td>Retinitis Pigmentosa
                        NCT01531348
                        </td>
        </tr>
    </table>
    </body>
</html>